Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


Articles published in Atherosclerosis

Retrieve available abstracts of 121 articles:
HTML format
Text format



Single Articles


    September 2019
  1. REIJRINK M, de Boer SA, Spoor DS, Lefrandt JD, et al
    Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Atherosclerosis. 2019;290:87-93.
    PubMed     Text format     Abstract available


    August 2019
  2. WEI W, Li XX, Xu M
    Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice.
    Atherosclerosis. 2019;289:132-142.
    PubMed     Text format     Abstract available


    July 2019
  3. MORELLI MB, Wang X, Santulli G
    Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease.
    Atherosclerosis. 2019 Jul 30. pii: S0021-9150(19)31425.
    PubMed     Text format    


  4. KABOOTARI M, Hasheminia M, Guity K, Ramezankhani A, et al
    Gestational diabetes mellitus in mothers and long term cardiovascular disease in both parents: Results of over a decade follow-up of the Iranian population.
    Atherosclerosis. 2019;288:94-100.
    PubMed     Text format     Abstract available


  5. BARCHUK M, Schreier L, Lopez G, Cevey A, et al
    Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 and angiopoietin-like protein 4 are associated with the increase of lipoprotein lipase activity in epicardial adipose tissue from diabetic patients.
    Atherosclerosis. 2019;288:51-59.
    PubMed     Text format     Abstract available


  6. ANHOLM C, Kumarathurai P, Pedersen LR, Samkani A, et al
    Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial.
    Atherosclerosis. 2019;288:60-66.
    PubMed     Text format     Abstract available


    June 2019
  7. QIU S, Cai X, Liu J, Yang B, et al
    Association between circulating cell adhesion molecules and risk of type 2 diabetes: A meta-analysis.
    Atherosclerosis. 2019;287:147-154.
    PubMed     Text format     Abstract available


    May 2019
  8. DE SILVA GS, Desai K, Darwech M, Naim U, et al
    Circulating serum fatty acid synthase is elevated in patients with diabetes and carotid artery stenosis and is LDL-associated.
    Atherosclerosis. 2019;287:38-45.
    PubMed     Text format     Abstract available


  9. KOWALL B, Stang A
    Reply to: "Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study"".
    Atherosclerosis. 2019 May 4. pii: S0021-9150(19)30401.
    PubMed     Text format    


    April 2019
  10. BIDHENDI YARANDI R, Panahi MH
    Methodological issues regarding "Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study".
    Atherosclerosis. 2019 Apr 17. pii: S0021-9150(19)30382.
    PubMed     Text format    


  11. CHEN Y, Dong J, Zhang X, Chen X, et al
    Evacetrapib reduces prebeta-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes.
    Atherosclerosis. 2019;285:147-152.
    PubMed     Text format     Abstract available


  12. RAO AD, Vaz CL, Williams KJ
    Accelerated atherosclerotic cardiovascular risk in type 1 diabetes mellitus: Time for a new idea?
    Atherosclerosis. 2019 Apr 14. pii: S0021-9150(19)30362.
    PubMed     Text format    


    March 2019
  13. SCHERNTHANER GH, Rami-Merhar B, Zierfuss B
    Gestational diabetes and maternal obesity suggestively priming children's premature atherosclerosis: Is it the mother fault?
    Atherosclerosis. 2019 Mar 4. pii: S0021-9150(19)30115.
    PubMed     Text format    


  14. HAGENSEN MK, Mortensen MB, Kjolby M, Palmfeldt J, et al
    Increased retention of LDL from type 1 diabetic patients in atherosclerosis-prone areas of the murine arterial wall.
    Atherosclerosis. 2019 Mar 4. pii: S0021-9150(19)30114.
    PubMed     Text format     Abstract available


  15. KOWALL B, Erbel R, Moebus S, Lehmann N, et al
    Decline in ankle-brachial index is stronger in poorly than in well controlled diabetes: Results from the Heinz Nixdorf Recall cohort study.
    Atherosclerosis. 2019;284:37-43.
    PubMed     Text format     Abstract available


    February 2019
  16. SUNDHOLM JKM, Litwin L, Rono K, Koivusalo SB, et al
    Maternal obesity and gestational diabetes: Impact on arterial wall layer thickness and stiffness in early childhood - RADIEL study six-year follow-up.
    Atherosclerosis. 2019 Feb 12. pii: S0021-9150(19)30064.
    PubMed     Text format     Abstract available


    January 2019
  17. LIU X, Li J, Liao J, Wang H, et al
    Gpihbp1 deficiency accelerates atherosclerosis and plaque instability in diabetic Ldlr(-/-) mice.
    Atherosclerosis. 2019;282:100-109.
    PubMed     Text format     Abstract available


    December 2018
  18. SAEED A, Sun W, Agarwala A, Virani SS, et al
    Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study.
    Atherosclerosis. 2018;282:52-56.
    PubMed     Text format     Abstract available


  19. WAKE M, Oh A, Onishi Y, Guelfucci F, et al
    Adherence and persistence to hyperlipidemia medications in patients with atherosclerotic cardiovascular disease and those with diabetes mellitus based on administrative claims data in Japan.
    Atherosclerosis. 2018;282:19-28.
    PubMed     Text format     Abstract available


  20. ZHAO Y, Evans MA, Allison MA, Bertoni AG, et al
    Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2018 Dec 15. pii: S0021-9150(18)31525.
    PubMed     Text format     Abstract available


    November 2018
  21. BOJANIN D, Vekic J, Milenkovic T, Vukovic R, et al
    Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
    Atherosclerosis. 2018;280:14-20.
    PubMed     Text format     Abstract available


  22. GUO J, Nunley KA, Costacou T, Miller RG, et al
    Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.
    Atherosclerosis. 2018;280:58-65.
    PubMed     Text format     Abstract available


    October 2018
  23. SAELY CH, Schindewolf M, Zanolin D, Heinzle CF, et al
    Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study.
    Atherosclerosis. 2018;279:32-37.
    PubMed     Text format     Abstract available


    September 2018
  24. BARTER PJ, Cochran BJ, Rye KA
    CETP inhibition, statins and diabetes.
    Atherosclerosis. 2018;278:143-146.
    PubMed     Text format     Abstract available


    August 2018
  25. BYUN JK, Choi BG, Rha SW, Choi SY, et al
    Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and non-ST-segment elevation myocardial infarction who underwent successful percutaneous coronary intervention.
    Atherosclerosis. 2018;277:130-135.
    PubMed     Text format     Abstract available


  26. MA M, Hui J, Zhang QY, Zhu Y, et al
    Long non-coding RNA nuclear-enriched abundant transcript 1 inhibition blunts myocardial ischemia reperfusion injury via autophagic flux arrest and apoptosis in streptozotocin-induced diabetic rats.
    Atherosclerosis. 2018;277:113-122.
    PubMed     Text format     Abstract available


  27. MUNOZ-HERNANDEZ L, Ortiz-Bautista RJ, Brito-Cordova G, Lozano-Arvizu F, et al
    Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes.
    Atherosclerosis. 2018;277:72-79.
    PubMed     Text format     Abstract available


    July 2018
  28. TASKINEN MR, Del Prato S, Bujas-Bobanovic M, Louie MJ, et al
    Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.
    Atherosclerosis. 2018;276:124-130.
    PubMed     Text format     Abstract available


  29. PALANCA A, Castelblanco E, Perpinan H, Betriu A, et al
    Prevalence and progression of subclinical atherosclerosis in patients with chronic kidney disease and diabetes.
    Atherosclerosis. 2018;276:50-57.
    PubMed     Text format     Abstract available


  30. PAN HC, Chou KM, Lee CC, Yang NI, et al
    Circulating Klotho levels can predict long-term macrovascular outcomes in type 2 diabetic patients.
    Atherosclerosis. 2018;276:83-90.
    PubMed     Text format     Abstract available


  31. HEIER M, Ofstad AP, Borja MS, Brunborg C, et al
    High-density lipoprotein function is associated with atherosclerotic burden and cardiovascular outcomes in type 2 diabetes.
    Atherosclerosis. 2018 Jul 6. pii: S0021-9150(18)31201.
    PubMed     Text format     Abstract available


    June 2018
  32. MIETTINEN HE, Rono K, Koivusalo SB, Eriksson JG, et al
    Effect of gestational diabetes mellitus on newborn cholesterol metabolism.
    Atherosclerosis. 2018;275:346-351.
    PubMed     Text format     Abstract available


    May 2018
  33. MANCINI GBJ, Boden WE, Brooks MM, Vlachos H, et al
    Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Atherosclerosis. 2018 May 31. pii: S0021-9150(18)30179.
    PubMed     Text format     Abstract available


  34. SUNG KC, Lee MY, Kim YH, Huh JH, et al
    Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Atherosclerosis. 2018;275:50-57.
    PubMed     Text format     Abstract available


  35. COLOMBO M, Looker HC, Farran B, Agakov F, et al
    Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Atherosclerosis. 2018;274:182-190.
    PubMed     Text format     Abstract available


  36. RAGGI P
    Angina severity, therapeutic choices and outcome in patients with diabetes mellitus.
    Atherosclerosis. 2018 May 3. pii: S0021-9150(18)30223.
    PubMed     Text format    


    April 2018
  37. WILCOX T, Newman JD, Maldonado TS, Rockman C, et al
    Peripheral vascular disease risk in diabetic individuals without coronary heart disease.
    Atherosclerosis. 2018 Apr 30. pii: S0021-9150(18)30211.
    PubMed     Text format     Abstract available


  38. MACEDONI M, Hovnik T, Plesnik E, Kotnik P, et al
    Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes.
    Atherosclerosis. 2018;273:53-58.
    PubMed     Text format     Abstract available


    March 2018
  39. SUAREZ-ORTEGON MF, McLachlan S, Price AH, Fernandez-Balsells M, et al
    Decreased iron stores are associated with cardiovascular disease in patients with type 2 diabetes both cross-sectionally and longitudinally.
    Atherosclerosis. 2018;272:193-199.
    PubMed     Text format     Abstract available


  40. AL-SHAREA A, Murphy AJ, Huggins LA, Hu Y, et al
    SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr(-/-) type 1 diabetic mice.
    Atherosclerosis. 2018;271:166-176.
    PubMed     Text format     Abstract available


  41. SINIARSKI A, Haberka M, Mostowik M, Golebiowska-Wiatrak R, et al
    Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Atherosclerosis. 2018;271:148-155.
    PubMed     Text format     Abstract available


    February 2018
  42. RAGGI P
    Atherosclerosis imaging to refine cardiovascular risk assessment in diabetic patients: Computed tomography and positron emission tomography applications.
    Atherosclerosis. 2018;271:77-83.
    PubMed     Text format     Abstract available


    December 2017
  43. LIGHTELL DJ JR, Moss SC, Woods TC
    Upregulation of miR-221 and -222 in response to increased extracellular signal-regulated kinases 1/2 activity exacerbates neointimal hyperplasia in diabetes mellitus.
    Atherosclerosis. 2017;269:71-78.
    PubMed     Text format     Abstract available


  44. TORRES-PENA JD, Garcia-Rios A, Delgado-Casado N, Gomez-Luna P, et al
    Mediterranean diet improves endothelial function in patients with diabetes and prediabetes: A report from the CORDIOPREV study.
    Atherosclerosis. 2017;269:50-56.
    PubMed     Text format     Abstract available


    November 2017
  45. CHRISTODOULOU E, Kadoglou NPE, Stasinopoulou M, Konstandi OA, et al
    Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
    Atherosclerosis. 2017 Nov 1. pii: S0021-9150(17)31370.
    PubMed     Text format     Abstract available


    October 2017
  46. GANJALI S, Dallinga-Thie GM, Simental-Mendia LE, Banach M, et al
    HDL functionality in type 1 diabetes.
    Atherosclerosis. 2017;267:99-109.
    PubMed     Text format     Abstract available


    September 2017
  47. MARCADENTI A, Fuchs FD, Moreira LB, Gus M, et al
    Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference.
    Atherosclerosis. 2017;266:145-150.
    PubMed     Text format     Abstract available


    August 2017
  48. SCHMIDT N, Schmidt B, Dressel A, Gergei I, et al
    Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.
    Atherosclerosis. 2017;266:24-30.
    PubMed     Text format     Abstract available


  49. CAMARGO GARCIA A, Garcia-Carpintero S, Lopez-Moreno J, Jimenez-Lucena R, et al
    Postprandial endotoxemia may influence the type 2 diabetes mellitus development.
    Atherosclerosis. 2017;263:e98.
    PubMed     Text format    


  50. STECHOVA K, Sklenarova J, Kratzerova T, Filipp D, et al
    Association between immune and lipid factors in women with diabetes type 1.
    Atherosclerosis. 2017;263:e97-e98.
    PubMed     Text format    


  51. EL KHOURY P, Roussel R, Fumeron F, Velho G, et al
    Plasma PCSK9 and cardiovascular events in type 2 diabetes.
    Atherosclerosis. 2017;263:e81.
    PubMed     Text format    


  52. WITKOWSKI M, Weithauser A, Tabaraie T, Steffens D, et al
    Endothelial micrornas epigenetically control vascular inflammation and thrombogenicity in diabetes.
    Atherosclerosis. 2017;263:e76.
    PubMed     Text format    


  53. SUN Y, Kopp S, Gali CC, Zandl M, et al
    Gestational diabetes mellitus modulates cholesterol metabolism in human fetoplacental endothelial cells.
    Atherosclerosis. 2017;263:e74-e75.
    PubMed     Text format    


  54. WALUS-MIARKA M, Idzior-Walus B, Trojak A, Kapusta M, et al
    Pentraxin 3 concentration in patients with type 2 diabetes mellitus and NAFLD.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    


  55. PITHOVA P, Pitha J, Stechova K, Kvapil M, et al
    Preclinical atherosclerosis is associated with insulin resistance in type 1 diabetes women.
    Atherosclerosis. 2017;263:e54.
    PubMed     Text format    


  56. IHM SH, Lee KY, Kim JJ, Hwang BH, et al
    CT Angiography-imaged coronary artery stenosis provides better risk prediction than traditional risk factors in asymptomatic diabetic individuals: A long-term study of clinical outcomes.
    Atherosclerosis. 2017;263:e53.
    PubMed     Text format    


  57. ILYAS Z, Al-Ghamdi J, Nguan-Soon T, Kiss-Toth E, et al
    Tribbles-3, a regulator of metabolic syndromes and type 2 diabetes.
    Atherosclerosis. 2017;263:e50.
    PubMed     Text format    


  58. CAVALCANTE MARANHAO R, Franca Marques A, Guido MC, Rufo Tavares E, et al
    Effects of treatment with methotrexate associated to lipid nanoparticles on diabetic cardiomyopathy in rats.
    Atherosclerosis. 2017;263:e48.
    PubMed     Text format    


  59. STOJIC I, Tepic S, Petkovic A, Srejovic I, et al
    Time dependent effects of hbot on redox status in diabetic patients.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    


  60. MANEA V, Pop C, Pop L
    Correlations of dipper profiles in diabetic patients with hypertension: the importance of ambulatory blood pressure monitoring/24 hours.
    Atherosclerosis. 2017;263:e276.
    PubMed     Text format    


  61. KYRIAZIS I, Sgouros K, Stefani D, Vallianou K, et al
    The effect of the presence and the level of dyslipidemia control on diabetic patients with first acute ischemic stroke.
    Atherosclerosis. 2017;263:e275-e276.
    PubMed     Text format    


  62. PITHA J, Pithova P, Roztocil K, Urbaniec K, et al
    Oliva-roztocil index, specific parameter of vascular damage in women suffering from diabetes mellitus.
    Atherosclerosis. 2017;263:e275.
    PubMed     Text format    


  63. KUMAR N, Khanna RK
    Anti-diabetic effect of trigonella foenum greacum seed acetone fraction in a type 2 diabetes model of rats.
    Atherosclerosis. 2017;263:e273.
    PubMed     Text format    


  64. BAUDIN B, Nekaies Y, Baudin B, Kelbousi S, et al
    Association of apolipoproteins plasma levels with PCSK9 in type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e273-e274.
    PubMed     Text format    


  65. RAJPUT S, Sinha S
    Modulation of the coexistence of diabetes and hypothyroidism on body weight gain, leptin and various metabolic aspects in wistar rats.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    


  66. DIOSZEGI A, Vass M, Nemeth N, Sogor V, et al
    Rheopheresis treatment of diabetic foot syndrome.
    Atherosclerosis. 2017;263:e272.
    PubMed     Text format    


  67. NANASY-VASS M, Dioszegi A, Flasko A, Mechler F, et al
    Study of microcirculatory impairment in type 2 diabetic patients with symptoms of peripherial neuropathy.
    Atherosclerosis. 2017;263:e272-e273.
    PubMed     Text format    


  68. SHALAEVA E, Janabaev B, Bobabekov A, Kasimov U, et al
    Coronary computed tomographic angiography and coronary artery calcium score in patients with type 2 diabetes undergoing trans-femoral amputation in 2013 in different clinical groups.
    Atherosclerosis. 2017;263:e271-e272.
    PubMed     Text format    


  69. ENA J, Perez S, Alvarez CE, Valls V, et al
    Triglyceride to high density lipoprotein cholesterol ratio, total cholesterol to high density lipoprotein cholesterol ratio and low ankle brachial index in patients with diabetes.
    Atherosclerosis. 2017;263:e270.
    PubMed     Text format    


  70. ENA J, Perez S, Argente CR, Lozano T, et al
    Systolic blood pressure difference between arms and peripheral arterial disease in patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e270-e271.
    PubMed     Text format    


  71. ZIVKOVIC V, Vranic A, Simovic S, Ristic P, et al
    The acute effects of different spironolactone doses on cardiac function in streptozotocine-induced diabetic rats.
    Atherosclerosis. 2017;263:e268-e270.
    PubMed     Text format    


  72. DUARTE JS, Bello C, Ferreira R, Limbert C, et al
    Atherogenic dislipidemia in patients with type 2 diabetes linked to microvascular complications and heart disease.
    Atherosclerosis. 2017;263:e265.
    PubMed     Text format    


  73. ZHILINA S, Miramontes Gonzalez JP, Laso Guzman FJ
    Familial hypercholesterolemia and the diabetogenic effect of statins.
    Atherosclerosis. 2017;263:e264.
    PubMed     Text format    


  74. BENEDI MVM, Calahorra SP, Sanz AMB, Baila Rueda L, et al
    A randomized, open-label study to investigate the effect of a high protein diet compared to a normoprotein diet on hydrocarbon metabolism in patients with diabetes or prediabetes and obesity.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    


  75. NIKOLOVA A, Milanova M, Stoyanov K, Yankov G, et al
    Risk assessment for diabetes mellitus type 2 in women.
    Atherosclerosis. 2017;263:e263-e264.
    PubMed     Text format    


  76. SZTANEK F, Seres I, Lorincz H, Molnar A, et al
    Effect of alpha-lipoic acid supplementation on oxidative stress markers and antioxidative defense in patients with diabetic neuropathy.
    Atherosclerosis. 2017;263:e263.
    PubMed     Text format    


  77. CASULA M, Mozzanica F, Scotti L, Tragni E, et al
    Statin use and risk of new-onset diabetes: a meta-analysis of observational studies.
    Atherosclerosis. 2017;263:e262-e263.
    PubMed     Text format    


  78. DOULAMIS I, Tzani A, Konstantopoulos P, Antoranz A, et al
    Targeted proteomics identification of biomarkers for diabetes mellitus in patients with cardiovascular disease.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    


  79. PARAGH G, Lorincz H, Somodi S, Varga VE, et al
    Serum afamin level is strongly associated to the components of metabolic syndrome in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e261.
    PubMed     Text format    


  80. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Ragino Y, et al
    The prevalence of dyslipidemia in young patients with diabetes mellitus.
    Atherosclerosis. 2017;263:e260-e261.
    PubMed     Text format    


  81. OVSYANNIKOVA A, Rymar O, Shaksthneider E, Voevoda M, et al
    Clinical case: The development of atherosclerosis in a patient 28 years old with 12 mody diabetes.
    Atherosclerosis. 2017;263:e260.
    PubMed     Text format    


  82. BARKAS F, Elisaf M, Liberopoulos E, Liamis G, et al
    Metabolic markers to predict incident diabetes in statin-treated individuals.
    Atherosclerosis. 2017;263:e259.
    PubMed     Text format    


  83. SHAKHTSHNEIDER E, Ovsyannikova A, Ivanoshchuk D, Rymar O, et al
    The spectrum of mutations in the CEL gene in early onset diabetes patients.
    Atherosclerosis. 2017;263:e259-e260.
    PubMed     Text format    


  84. GARCIA-DONAIRE JA, Franch-Nadal J, Rodriguez-Fortunez P, Labrador-Barba E, et al
    The importance of the training as an integral part of caring for the diabetic patient. FORMA2 study: Differences between urban and rural work area.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    


  85. SHALIMOVA A, Bilovol O, Bobronnikova L
    Severity of cardiovascular remodeling in comorbidity of essential hypertension and type 2 diabetes depending on genetic polymorphism of AGTR1 and IRS-1.
    Atherosclerosis. 2017;263:e258.
    PubMed     Text format    


  86. HAN Y, Jang YN, Lee YJ, Kim HM, et al
    Fimasartan nomalizes carbohydrate metabolism through AMPK pathway in diabetic condition.
    Atherosclerosis. 2017;263:e258-e259.
    PubMed     Text format    


  87. VONBANK A, Zanolin D, Leiherer A, Rein P, et al
    The power of thyroid stimulating hormone to predict cardiovascular mortality in non-obese patients is significantly modulated by type 2 diabetes.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  88. SAELY C, Vonbank A, Zanolin D, Leiherer A, et al
    Single and joint effects of obesity and of the metabolic syndrome on the development of diabetes in patients with coronary atherosclerosis.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  89. SAELY C, Rein P, Leiherer A, Vonbank A, et al
    Remnant cholesterol predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease.
    Atherosclerosis. 2017;263:e256.
    PubMed     Text format    


  90. SAELY C, Zanolin D, Rein P, Leiherer A, et al
    Concordance of glucose-based and of HbA1c-based diagnoses of diabetes in patients with peripheral arterial disease-a comparison between men and women.
    Atherosclerosis. 2017;263:e255.
    PubMed     Text format    


  91. SAELY C, Zanolin D, Vonbank A, Leiherer A, et al
    Non-alcoholic fatty liver disease strongly predicts incident diabetes in patients with coronary artery disease.
    Atherosclerosis. 2017;263:e255-e256.
    PubMed     Text format    


  92. DEMIKHOVA N, Chernatska O, Smiianova O, Vynnychenko L, et al
    The correlation between polimorphism of CYP7a1 gene and glycated hemoglobin in hypertensive patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    


  93. KIM BJ, Han JM, Do JH, Kim BS, et al
    Sex-specific relationship between cotinine-verified second-hand smoke exposure and diabetes in 85,697 never-smokers.
    Atherosclerosis. 2017;263:e254.
    PubMed     Text format    


  94. EISENGA M, Zelle D, Sloan J, Gaillard C, et al
    High serum PCSK9 is associated with increased risk of new-onset diabetes after transplantation in renal transplant recipients.
    Atherosclerosis. 2017;263:e254-e255.
    PubMed     Text format    


  95. MITSUTAKE R
    Effect of canagliflozin on visceral fat area and heart rate in patients with type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e252.
    PubMed     Text format    


  96. FULOP P, Seres I, Lorincz H, Somodi S, et al
    Lipocalin 2 may be a potential biomarker of atherosclerotic complications in obese non-diabetic individuals.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    


  97. SZENTPETERI A, Lorincz H, Somodi S, Varga VE, et al
    Human obestatin level and its correlations with metabolic syndrome components in non-diabetic obese patients.
    Atherosclerosis. 2017;263:e250.
    PubMed     Text format    


  98. KARASEK D, Gajdova J, Kubickova V, Krystynik O, et al
    Selected adipokines in patients with type 2 diabetes: Relationship to soluble markers of endothelial dysfunction-a pilot study.
    Atherosclerosis. 2017;263:e249.
    PubMed     Text format    


  99. ASKRI I, Kelbousi S, Sakly M, Attia N, et al
    Atorvastatin effect on phospholipid profile and distribution between lipoprotein fractions in type 2 diabetic patients with and without CAD.
    Atherosclerosis. 2017;263:e246.
    PubMed     Text format    


  100. YASUDA H, Fujiwara A, Komiya S, Haze T, et al
    Effects of rosuvastatin add-on treatment on hyperlipidemia in type 2 diabetic patients with chronic kidney disease receiving ethyl icosapentate.
    Atherosclerosis. 2017;263:e241-e242.
    PubMed     Text format    


  101. BATURINA O, Mironova O
    Clinical case of hyperlipidemia type IV in a man with diabetes, myocardial infarction and stroke.
    Atherosclerosis. 2017;263:e227-e228.
    PubMed     Text format    


  102. MAGLAPHERIDZE Z, Tabukashvili R, Kapetivadze V, Tchaava K, et al
    Treatment of dyslipidemia in diabetic type 2 patients with hypertension.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    


  103. MARANHAO RC, Tavoni TM, Laverdy Neto OG, Sprandel MDCO, et al
    Differences in lipid transfers to HDL between patients with coronary arterial disease with or without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e217.
    PubMed     Text format    


  104. ARAGONA CO, Cairo V, Scuruchi M, Giunta L, et al
    Evaluation of Lp(a) and insulin during pregnancy in not diabetic women. Preliminary data.
    Atherosclerosis. 2017;263:e208.
    PubMed     Text format    


  105. WALUS-MIARKA M, Trojak A, Kapusta M, Idzior-Walus B, et al
    Pentraxin 3 concentration is positively associated with apo C3 and abdominal obesity in men with type 2 diabetes.
    Atherosclerosis. 2017;263:e207.
    PubMed     Text format    


  106. VASILKOVA V, Mokhort T, Naumenko E, Zmailik M, et al
    Association between systolic dysfunction and inflammation in diabetic patients with chronic kidney disease.
    Atherosclerosis. 2017;263:e191.
    PubMed     Text format    


  107. LAKHOUA Y, Ben Nacef I, Bouzid K, M'Chrirgui N, et al
    Prevalence of diabetes and frequency of cardiovascular risk factors in paramedical and administrative staff of Charles Nicolle hospital.
    Atherosclerosis. 2017;263:e180-e181.
    PubMed     Text format    


  108. VONBANK A, Saely C, Rein P, Leiherer A, et al
    The visceral adiposity index predicts cardiovascular events both in coronary artery disease patients with and in coronary artery disease patients without diabetes.
    Atherosclerosis. 2017;263:e172-e173.
    PubMed     Text format    


  109. VIKULOVA O, Bolotskaya L, Bessmertnaya E, Artemova E, et al
    Frequency of diabetic complications and HbA1C level by active screening and diabetes registry data: Comparative study.
    Atherosclerosis. 2017;263:e171.
    PubMed     Text format    


  110. KONSTANTOPOULOS P, Tzani A, Doulamis IP, Korou ML, et al
    Anti-inflammatory, hypolipidemic and hepatoprotective properies of CMG in an experimental model of diabetes.
    Atherosclerosis. 2017;263:e166-e167.
    PubMed     Text format    


  111. REVNIC CR, Revnic F, Pena C, Nica AS, et al
    The role of physical training on neuroendocrine axis, physiology and metabolism in elderly with/without diabetes.
    Atherosclerosis. 2017;263:e161.
    PubMed     Text format    


  112. KUMAR S, Sharma V
    Hypertension, obesity, diabetes, and heart failure-free survival: The cardiovascular disease lifetime risk pooling project in New Delhi, India.
    Atherosclerosis. 2017;263:e159.
    PubMed     Text format    


  113. NOVAKOVIC R, Cirovic S, Markovic-Lipkovski J, Rajkovic J, et al
    Effect of polyphenol resveratrol on the isolated renal artery of normal and diabetic rats.
    Atherosclerosis. 2017;263:e157.
    PubMed     Text format    


  114. STOJANOVIC M, Radenkovic M
    Clarification of serotonin-induced effects in peripheral artery disease via the rat femoral artery response in models of diabetes and vascular occlusion.
    Atherosclerosis. 2017;263:e133-e134.
    PubMed     Text format    


  115. RAJKOVIC J, Peric M, Stanisic J, Rakocevic J, et al
    Involvement of ATP-sensitive potassium channels in effect of pinacidil on saphenous vein obtained from the patients with and without type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e131.
    PubMed     Text format    


  116. NIKOLOV A, Tsinlikov I, Tsinlikova I, Nicoloff G, et al
    Levels of anti-elastin IgA antibodies are associated with high risk of atherosclerosis in diabetics with essential hypertension.
    Atherosclerosis. 2017;263:e124-e125.
    PubMed     Text format    


  117. MELNIKOV I, Gabbasov Z, Kozlov S, Byazrova S, et al
    Assessment of novel biomarkers for restenosis occurrence after drug-eluting stent implantation in patients with stable coronary artery disease and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e121-e122.
    PubMed     Text format    


  118. VIRTA J, Silvola J, Hellberg S, Stahle M, et al
    Effects of linagliptin intervention on atherosclerotic plaque inflammation and 18F-FDG uptake in a mouse model of type 2 diabetes.
    Atherosclerosis. 2017;263:e119-e120.
    PubMed     Text format    


  119. PETELINA T, Musikhina N, Gapon L, Emeneva I, et al
    Features of atherogenic lipid profile and inflammatory markers in patients with stable angina and type 2 diabetes mellitus.
    Atherosclerosis. 2017;263:e118.
    PubMed     Text format    


  120. KULIKOWSKI E, Calosing C, Tsujikawa L, Wasiak S, et al
    Apabetalone (RVX-208) may lower CVD events in diabetes mellitus by affecting complement pathway and microbiome activity.
    Atherosclerosis. 2017;263:e113.
    PubMed     Text format    


  121. POVLSEN GK, Langhi C, Skytte Olsen G
    Regulation of hepatic LDL-receptor and PCSK9 expression by insulin in diabetic mice and in vitro in hepatocyte models.
    Atherosclerosis. 2017;263:e102.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: